Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.57) per share. This is a 26.67 percent decrease over losses of $(0.45) per share from the same period last year.
Stifel Maintains Buy on Ballys, Lowers Price Target to $58
Stifel maintains Ballys (NYSE:BALY) with a Buy and lowers the price target from $70 to $58.